Component
Low-density lipoprotein particles; preparation specified
Low-density lipoprotein particles; preparation specified. Species, exposure and limitations are retained in each linked claim.
11 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
LDL delivery produced the greatest lutein uptake in the tested ARPE-19 system.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lutein-research/27538825.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3", "start_char": 0, "end_char": 1346, "text_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3"}
- experimental_model
- Carotenoid delivery using isolated human lipoproteins
- exposure
- Carotenoid-loaded LDL versus HDL
- limitations
- Cell delivery ranking is not identical to circulating carriage fractions or the WHAM-chicken phenotype.
- nutrient_topic
- Lutein research collection; topical membership is not evidence of a direct dietary effect. · Lutein
- organism
- Human ARPE-19 cells
- plain_language
- The best carrier in this cell assay was LDL.
- primary_references
- [lutein-p27538825] Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins. (2016). https://pubmed.ncbi.nlm.nih.gov/27538825/ DOI: 10.1194/jlr.m070193
- tissue_or_cell_type
- Retinal pigment epithelial model
Lutein: metabolism, signaling and nutrient connections (2026-09-17) · lines 632–643
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Carotenoid delivery using isolated human lipoproteins · source_derived_draft · unverified_draft
### lutein-ldl-rpe-delivery LDL delivery produced the greatest lutein uptake in the tested ARPE-19 system. Condition category: normal nutrient_topic: Lutein research collection; topical membership is not evidence of a direct dietary effect. plain_language: The best carrier in this cell assay was LDL. organism: Human ARPE-19 cells tissue_or_cell_type: Retinal pigment epithelial model experimental_model: Carotenoid delivery using isolated human lipoproteins limitations: Cell delivery ranking is not identical to circulating carriage fractions or the WHAM-chicken phenotype. exposure: Carotenoid-loaded LDL versus HDL evidence_span: {"source_cache": "artifacts/lutein-research/27538825.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3", "start_char": 0, "end_char": 1346, "text_sha256": "1db014221931676349f15dc3c5138fba122417fb49fec5de481594c72b0596f3"} [lutein-p27538825] Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins. (2016). https://pubmed.ncbi.nlm.nih.gov/27538825/ DOI: 10.1194/jlr.m070193
Complete structured claim and evidence
What acts on it
Adding betanin to human plasma produced pigment-enriched LDL after particle isolation.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- Adding betanin to human plasma produced pigment-enriched LDL after particle isolation.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 47–55
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-betanin-ldl-binding Adding betanin to human plasma produced pigment-enriched LDL after particle isolation. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidenceAdding indicaxanthin to human plasma produced pigment-enriched LDL after particle isolation.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- Adding indicaxanthin to human plasma produced pigment-enriched LDL after particle isolation.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 67–75
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-indicaxanthin-ldl-binding Adding indicaxanthin to human plasma produced pigment-enriched LDL after particle isolation. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidence
Where it participates (unsigned role)
Astaxanthin appeared in chylomicron/VLDL-rich, LDL and HDL plasma fractions after the meal; transport was not confined to one lipoprotein class.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Same three-person single-dose study.
- limitations
- Distribution is not proof of delivery to a particular organ or entry across the human blood-brain barrier.
- nutrient_topic
- Astaxanthin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Astaxanthin
- plain_language
- Several blood lipid carriers transported it.
- primary_references
- Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11120445/ · DOI 10.1016/s0955-2863(00)00104-2
Astaxanthin: transport, membrane chemistry, signaling and nutrient interactions (2026-09-19) · lines 78–84
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Same three-person single-dose study. · source_derived_draft · unverified_draft
## astaxanthin-lipoprotein-distribution Several blood lipid carriers transported it. Astaxanthin appeared in chylomicron/VLDL-rich, LDL and HDL plasma fractions after the meal; transport was not confined to one lipoprotein class. Model: Same three-person single-dose study. Limitations: Distribution is not proof of delivery to a particular organ or entry across the human blood-brain barrier. Evidence access: Primary abstract Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11120445/ · DOI 10.1016/s0955-2863(00)00104-2
Complete structured claim and evidenceLDL enriched with betanin showed a longer lag before copper-induced oxidation.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- LDL enriched with betanin showed a longer lag before copper-induced oxidation.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 57–65
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-betanin-ldl-oxidation LDL enriched with betanin showed a longer lag before copper-induced oxidation. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidenceBetanin did not produce the early vitamin E preservation observed with indicaxanthin in this LDL experiment.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- Betanin did not produce the early vitamin E preservation observed with indicaxanthin in this LDL experiment.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 97–105
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-betanin-vitamin-e-null Betanin did not produce the early vitamin E preservation observed with indicaxanthin in this LDL experiment. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidenceLDL isolated 3 and 5 h after cactus pear ingestion resisted ex vivo oxidation more strongly; LDL vitamin E and beta-carotene levels were unchanged.
Experimental context and source evidence
- dose
- Single 500 g cactus pear pulp meal: 28 mg indicaxanthin and 16 mg betanin
- duration
- Plasma/urine followed for 12 h
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Eight healthy human volunteers
- limitations
- Whole-food exposure cannot attribute the LDL response exclusively to either pigment; urinary recovery is not absolute absorption.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Eight healthy human volunteers
- plain_language
- LDL isolated 3 and 5 h after cactus pear ingestion resisted ex vivo oxidation more strongly; LDL vitamin E and beta-carotene levels were unchanged.
- primary_references
- Absorption, excretion, and distribution of dietary antioxidant betalains in LDLs: potential health effects of betalains in humans. (2004). https://pubmed.ncbi.nlm.nih.gov/15447903/ DOI: 10.1093/ajcn/80.4.941
- route
- Oral whole food
- tissue
- Plasma, urine and isolated LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 517–525
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Eight healthy human volunteers · source_derived_draft · unverified_draft
## betalains-human-food-ldl LDL isolated 3 and 5 h after cactus pear ingestion resisted ex vivo oxidation more strongly; LDL vitamin E and beta-carotene levels were unchanged. Model/species: Eight healthy human volunteers Tissue: Plasma, urine and isolated LDL Exposure: Single 500 g cactus pear pulp meal: 28 mg indicaxanthin and 16 mg betanin Route: Oral whole food Duration: Plasma/urine followed for 12 h Limits: Whole-food exposure cannot attribute the LDL response exclusively to either pigment; urinary recovery is not absolute absorption. Primary reference: Absorption, excretion, and distribution of dietary antioxidant betalains in LDLs: potential health effects of betalains in humans. (2004). https://pubmed.ncbi.nlm.nih.gov/15447903/ DOI: 10.1093/ajcn/80.4.941
Complete structured claim and evidenceLDL enriched with indicaxanthin showed a longer lag before copper-induced oxidation.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- LDL enriched with indicaxanthin showed a longer lag before copper-induced oxidation.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 77–85
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-indicaxanthin-ldl-oxidation LDL enriched with indicaxanthin showed a longer lag before copper-induced oxidation. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidenceIndicaxanthin preserved LDL vitamin E early during oxidation; combined action protected LDL more than sequential separate action.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. The authors infer assay synergy; direct tocopheroxyl-radical recycling is not established.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- Indicaxanthin preserved LDL vitamin E early during oxidation; combined action protected LDL more than sequential separate action.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 87–95
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-indicaxanthin-vitamin-e Indicaxanthin preserved LDL vitamin E early during oxidation; combined action protected LDL more than sequential separate action. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. The authors infer assay synergy; direct tocopheroxyl-radical recycling is not established. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidenceBetanin reduced lipid hydroperoxide formation during MPO/nitrite-mediated oxidation of human LDL.
Experimental context and source evidence
- dose
- Experimental betanin addition; concentration not specified in accessed abstract
- duration
- Oxidation time courses; duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Isolated human LDL and MPO/nitrite biochemical system
- limitations
- Oxidation products were not chemically identified; clinical LDL lowering was not tested.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Isolated human LDL and MPO/nitrite biochemical system
- plain_language
- Betanin reduced lipid hydroperoxide formation during MPO/nitrite-mediated oxidation of human LDL.
- primary_references
- Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins. (2007). https://pubmed.ncbi.nlm.nih.gov/17364963/ DOI: 10.1080/10715760601038783
- route
- In vitro addition
- tissue
- LDL lipid compartment
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 187–195
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Isolated human LDL and MPO/nitrite biochemical system · source_derived_draft · unverified_draft
## betalains-mpo-ldl Betanin reduced lipid hydroperoxide formation during MPO/nitrite-mediated oxidation of human LDL. Model/species: Isolated human LDL and MPO/nitrite biochemical system Tissue: LDL lipid compartment Exposure: Experimental betanin addition; concentration not specified in accessed abstract Route: In vitro addition Duration: Oxidation time courses; duration not specified in accessed abstract Limits: Oxidation products were not chemically identified; clinical LDL lowering was not tested. Primary reference: Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins. (2007). https://pubmed.ncbi.nlm.nih.gov/17364963/ DOI: 10.1080/10715760601038783
Complete structured claim and evidenceUnidentified products generated by MPO/nitrite oxidation of betanin also inhibited LDL oxidation in the assay.
Experimental context and source evidence
- dose
- Experimental betanin addition; concentration not specified in accessed abstract
- duration
- Oxidation time courses; duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Isolated human LDL and MPO/nitrite biochemical system
- limitations
- Oxidation products were not chemically identified; clinical LDL lowering was not tested.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Isolated human LDL and MPO/nitrite biochemical system
- plain_language
- Unidentified products generated by MPO/nitrite oxidation of betanin also inhibited LDL oxidation in the assay.
- primary_references
- Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins. (2007). https://pubmed.ncbi.nlm.nih.gov/17364963/ DOI: 10.1080/10715760601038783
- route
- In vitro addition
- tissue
- LDL lipid compartment
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 197–205
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Isolated human LDL and MPO/nitrite biochemical system · source_derived_draft · unverified_draft
## betalains-oxidation-products Unidentified products generated by MPO/nitrite oxidation of betanin also inhibited LDL oxidation in the assay. Model/species: Isolated human LDL and MPO/nitrite biochemical system Tissue: LDL lipid compartment Exposure: Experimental betanin addition; concentration not specified in accessed abstract Route: In vitro addition Duration: Oxidation time courses; duration not specified in accessed abstract Limits: Oxidation products were not chemically identified; clinical LDL lowering was not tested. Primary reference: Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins. (2007). https://pubmed.ncbi.nlm.nih.gov/17364963/ DOI: 10.1080/10715760601038783
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.